NIH-funded research R21 grant

Gastrointestinal Colonization of carbapenem-resistant Enterobacter hormaeae (ECC) in the gut

Official title: Gastrointestinal Colonization Mechanisms of Carbapenem-Resistant?Enterobacter hormaechei

Funded at Michigan State University · NIH-11442316 · Data updated 2026-11-12

This grant explores how a deadly gut bacteria (carbapenem-resistant Enterobacter hormaeae) takes hold in the intestines and spreads, with the goal of preventing infections in patients.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMichigan State University
NIH-funded
Lab location1 site (East Lansing, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$436,309
NIH project number1R21AI202631-01
Project IDNIH-11442316 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include neonates and adults at risk for CRE infections, particularly those in hospital or ICU settings.

Less likely to help

Caregivers and patients not exposed to CRE in healthcare settings may not directly benefit.

What this research studies

The project uses a neonatal mouse model to study how ECC bacteria colonize the gut, which nutrients support their growth, and which factors help them attach to the intestinal lining. Researchers aim to identify key steps in colonization that could be blocked to prevent hospital-acquired and invasive infections. The findings could inform new strategies to reduce transmission and severity of CRE infections in vulnerable patients. This work targets understanding a human health threat while using an animal model to reveal mechanisms relevant to patient care.

Why it matters

Potential benefit: Improved understanding of how CRE colonizes the gut could lead to interventions that prevent serious infections in newborns and high-risk adults.

How similar studies have gone: Previous models and studies have shown that gut colonization is a critical step in CRE infections, with potential for translation to prevention strategies.

Where this research is happening

  • Michigan State University
    East Lansing, United States
    Active

Researchers

  • Principal investigator: Dirita, Victor J. — Michigan State University
  • Study coordinator: Dirita, Victor J.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.